Preview: Oligos and Peptides

This European Magazine special issue will deal with hot topics in oligonucleotide & peptide design, as well as analytics and manufacturing. RNA and peptide drugs, such as the new GLP1 receptor agonists, are the rising stars after the COVID-19 pandemic. A US$125bn global market is emerging for peptide drugs in obesity alone. AI specialists, analytics service providers, vector or LNP experts as well as contract research and manufacturing organisations will have the opportunity to present their expertise and market know-how in this special feature.